
Virtual Physiological Human Institute
Virtual Physiological Human Institute
2 Projects, page 1 of 1
assignment_turned_in Project2023 - 2028Partners:NHS ENGLAND, Imperial College London, ANSYS, University of Glasgow, HDR UK +17 partnersNHS ENGLAND,Imperial College London,ANSYS,University of Glasgow,HDR UK,University of Ulster,GlaxoSmithKline (Global),JLU,Ada Lovelace Institute,Medical University of Graz,Virtual Physiological Human Institute,UNIVERSITY OF CAMBRIDGE,University of Heidelberg,Synopsys (UK),Swansea University,USA Food and Drug Administration,Simula,Medicines & Healthcare pdts Reg Acy MHRA,AstraZeneca (Global),Mott Macdonald (United Kingdom),UK Pulmonary Hypertension Association,Medtronic (United States)Funder: UK Research and Innovation Project Code: EP/Z531297/1Funder Contribution: 8,844,330 GBPNetworks of Cardiovascular Digital Twins (CVD-Net): Transforming Healthcare through Personalised Predictive Modelling The Networks of Cardiovascular Digital Twins (CVD-Net) Programme Grant aims to revolutionise healthcare by harnessing the power of digital twin (DT) technology. Patient DTs are virtual replicas that continuously assimilate patient data into sophisticated models to provide personalised predictions and inform clinical decisions. Healthcare, despite its national importance (consuming 12% of GDP, generating £70 billion/year and 240,000 jobs), remains unserved by DT technologies. CVD-Net will build a critical mass of research around patient DTs for healthcare, identify the challenges and opportunities in the clinical setting, and provide a roadmap for NHS implementation. We take the view that we must begin by focussing on a specific clinical use case, and that we need to learn by doing, using real-world data, on clinical timescales and making testable predictions. We propose a flexible Programme structure built around developing a minimum viable DT, then testing, optimising, and evaluating the this over iterative design cycles. We focus on pulmonary arterial hypertension (PAH), a life-threatening cardiovascular disease with high mortality and adverse event rates, as a specific use case to develop a demonstrator NHS DT care pathway. The public and patients are receptive to the idea of DTs with 90% (173/196) agreeing with the statement "I would find a digital twin smartphone app that represents my individual cardiovascular health useful". PAH patients suffer high mortality, frequent clinical worsening events and are served by a limited number of national centres. These high event rates and concentration of patients make it possible (and important) to develop and test the forecasting capabilities of a DT in proof-of-concept studies within CVD-Net. Our objective is to create a comprehensive patient DT that can monitor and forecast disease progression, treatment response, and quality of life for individual patients. The DTs will combine data from hospitals, wearable and implantable sensors, and patient-reported outcomes. To realise DTs at the scale and speed of a clinical service, we propose a novel networking approach, where individual "digital threads" (within a DT) will be 'woven' together to form an interconnected 'digital tapestry' to facilitate shared learning and communication. We will utilise innovative techniques including knowledge graphs, transfer learning, federated learning, and meta-learning to address scalability, variability, uncertainty, and data security challenges. We have brought together a unique interdisciplinary team of engineers, clinicians, computational statisticians, and research engineers to deliver CVD-Net. We will access retrospective and collect prospective data to train, test and validate the network of DTs. We will build the IT infrastructure, and analysis workflows to run a demonstrator DT care pathway within the NHS infrastructure. We will work with patients, clinicians, and stakeholders to assess its usability and added value. Via stakeholder engagement, we will evaluate the feasibility, scalability, and wider adoption potential of networked patient DTs in patient care. By generating robust evidence and understanding patient, clinician, and policy considerations, by completion of CVD-Net, we aim to have moved DTs towards prospective evaluation in a clinical trial. Ultimately, CVD-Net has the potential to transform healthcare by providing personalised predictive modelling, enhancing clinical decision-making, and improving patient outcomes. Its applications will benefit patients, clinicians, policymakers, and the research community, making healthcare more precise and efficient while contributing to the transformation of NHS care.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::46e6d98ced2e4f57c1d6799737bcd4bd&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::46e6d98ced2e4f57c1d6799737bcd4bd&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2023 - 2028Partners:Information Junction Ltd, Association of Chief Police Officers, AstraZeneca (United Kingdom), Arup Group (United Kingdom), Viettel Group +37 partnersInformation Junction Ltd,Association of Chief Police Officers,AstraZeneca (United Kingdom),Arup Group (United Kingdom),Viettel Group,Environment Agency,Dover Harbour Board (DHB),GSK (Global),KEEN AI Ltd,Pinsent Masons (United Kingdom),Newcastle Health Innovation Partners,COWI UK Limited,Jacobs,Port of Tyne,Scotland's Rural College,Network Rail,Nissan (United Kingdom),Hadean Supercomputing Ltd,Ansys (United States),Virtual Physiological Human Institute,Qinetiq (United Kingdom),Fujitsu (United Kingdom),Iknaia Limited,AddQual,Connected Places Catapult,Discovery Park Limited,Health and Safety Executive,BTL Group LTD,UK Coll for Res in Infra & Cities UKCRIC,DAFNI Data & Analytics Fac f Natl Infra,BMT Group (United Kingdom),The National Robotarium,The Alan Turing Institute,STFC,The MathWorks Inc,EDF Energy (United Kingdom),Medtronic (United States),Scottish Research Partnership in Eng,Anglian Water Services (United Kingdom),Be-St,UK Research Centre in NDE,Digital CatapultFunder: UK Research and Innovation Project Code: EP/Y016289/1Funder Contribution: 3,214,310 GBPDigital twins are a fusion of digital technologies considered by many leading advocates to be revolutionary in nature. Digital twins offer exciting new possibilities across a wide range of sectors from health, environment, transport, manufacturing, defence, and infrastructure. By connecting the virtual and physical worlds (e.g. cyber-physcial), digital twins are able to better support decisions, extend operational lives, and introduce multiple other efficiencies and benefits. As a result, digital twins have been identified by government, professional bodies and industry, as a key technology to help address many of the societal challenges we face. To date, digital twin (DT) innovation has been strongly driven by industry practitioners and commercial innovators. As would be expected with any early-adoption approach, projects have been bespoke & often isolated, and so there is a need for research to increase access, lower entry costs and develop interconnectivity. Furthermore, there are several major gaps in underpinning academic research relating to DT. The academic push has been significantly lagging behind the industry pull. As a result, there is an urgent need for a network that will fill gaps in the underpinning research for topics such as; uncertainty, interoperability, scaling, governance & societal effects. In terms of existing networking activities, there are several industry-led user groups and domain-specific consortia. However, there has never been a dedicated academic-led DT network that brings together academic research teams across the entire remit of UKRI with user-led groups. DTNet+ will address this gap with a consortium which has both sufficient breadth and depth to deliver transformative change.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::ddc485f41f418fe646265cde970a35d2&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::ddc485f41f418fe646265cde970a35d2&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu